The diagnostic value of pepsin concentration in saliva for laryngopharyngeal reflux disease
- PMID: 35689682
- DOI: 10.1007/s00405-022-07472-x
The diagnostic value of pepsin concentration in saliva for laryngopharyngeal reflux disease
Abstract
Objective: To explore the diagnostic efficacy of pepsin concentration in saliva for laryngopharyngeal reflux (LPR) disease.
Methods: In this study, we recruited 40 participants with abnormal sensation of throat into the study who visited our hospital from March 2020 to December 2020. The 24 h multichannel intraluminal impedance and pH monitoring (24 h MII-pH), reflux symptom index (RSI) and reflux finding score (RFS), pepsin concentration in saliva were collected. The Cohen's kappa test and receiver-operating characteristic (ROC) curves were performed to determine and compare the sensitivity and specificity of five diagnostic methods: RSI; RFS, pepsin concentration, RSI + RFS, RSI + RFS + pepsin concentration.
Results: The area under the curve (AUC) of RSI, RFS, pepsin concentration, RSI + RFS, RSI + RFS + pepsin concentration were 0.767, 0.733, 0.870, 0.750,0.867, respectively. That is, the pepsin concentration has maximum AUC (the cutoff point is 219.47 (ng/mL); the sensitivity and 1-specificity is 0.300, 0.933, respectively.). The positive predictive value was 90.3% (28/31), and the negative predictive value was 77.8% (7/9). The Cohen's kappa coefficients of the five diagnostic subgroups were: RSI 0.486 (95% CI 0.207-0.764, P = 0.001); RFS 0.333 (95% CI 0.021-0.644, P = 0.032); RSI + RFS: 0.517 (95% CI 0.205-0.829, P = 0.001); pepsin concentration: 0.699 (95% CI 0.379-0.931, P = 0.001); RSI + RFS + pepsin concentration: 0.500 (95% CI 0.181-0.819, P < 0.001).
Conclusion: The pepsin concentration has the maximum AUC area and highest consistency with the 24 h MII-pH. Therefore, it has certain value in the screening and diagnosis of diseases related to LPR disease.
Keywords: Laryngopharyngeal reflux; Pepsin concentration; RFS; RSI.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux.Laryngoscope. 2020 Jul;130(7):1780-1786. doi: 10.1002/lary.28320. Epub 2019 Oct 11. Laryngoscope. 2020. PMID: 31603541 Free PMC article.
-
Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin?Respir Med. 2015 Aug;109(8):963-9. doi: 10.1016/j.rmed.2015.05.019. Epub 2015 May 22. Respir Med. 2015. PMID: 26044812
-
Role of Pepsin and Oropharyngeal pH-Monitoring to Assess the Postoperative Outcome of Patients with Laryngopharyngeal Reflux: Results of a Pilot Trial.J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):937-943. doi: 10.1089/lap.2017.0360. Epub 2017 Jul 21. J Laparoendosc Adv Surg Tech A. 2017. PMID: 28731842
-
[Current possibilities and challenges in the diagnosis of laryngopharyngeal reflux].HNO. 2021 Nov;69(11):861-867. doi: 10.1007/s00106-021-01006-3. Epub 2021 Feb 22. HNO. 2021. PMID: 33619606 Free PMC article. Review. German.
-
Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux: a meta-analysis.Eur Arch Otorhinolaryngol. 2018 Mar;275(3):671-678. doi: 10.1007/s00405-017-4845-8. Epub 2017 Dec 13. Eur Arch Otorhinolaryngol. 2018. PMID: 29238875 Review.
Cited by
-
[Consistency analysis of pepsin immunohistochemistry and pepsin test box in the diagnosis of laryngopharyngeal reflux].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Feb;37(2):97-102;106. doi: 10.13201/j.issn.2096-7993.2023.02.004. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023. PMID: 36756822 Free PMC article. Chinese.
-
Identifying causal relationships between gastroesophageal reflux and extraesophageal diseases: A Mendelian randomization study.Medicine (Baltimore). 2024 Feb 16;103(7):e37054. doi: 10.1097/MD.0000000000037054. Medicine (Baltimore). 2024. PMID: 38363933 Free PMC article.
-
Diagnostic value of fasting hypopharyngeal salivary pepsin concentration test for laryngopharyngeal reflux disease.World J Otorhinolaryngol Head Neck Surg. 2024 Jul 17;11(2):241-249. doi: 10.1002/wjo2.200. eCollection 2025 Jun. World J Otorhinolaryngol Head Neck Surg. 2024. PMID: 40535736 Free PMC article.
-
Saliva pepsin measurements in the detection of gastroesophageal reflux disease in laryngopharyngeal reflux patients: a cohort study.Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3765-3771. doi: 10.1007/s00405-023-08000-1. Epub 2023 May 4. Eur Arch Otorhinolaryngol. 2023. PMID: 37140740
References
-
- Lechien JR, Saussez S, Schindler A et al (2019) Clinical outcomes of laryngopharyngeal reflux treatment: a systematic review and meta-analysis. Laryngoscope 129(5):1174–1187 - DOI
-
- Mccormick CA, Samuels TL, Battle MA et al (2020) H+/K+ATPase expression in the larynx of laryngopharyngeal reflux and laryngeal cancer patients. Laryngoscope 131(1):130–135 - DOI
-
- Lechien JR, Saussez S, Nacci A et al (2019) Association between laryngopharyngeal reflux and benign vocal folds lesions: a systematic review. Laryngoscope 129(9):E329–E341 - DOI
-
- Kakaje A, Alhalabi MM, Alyousbashi A et al (2021) Allergic rhinitis, asthma and laryngopharyngeal reflux disease: a cross-sectional study on their reciprocal relations. Sci Rep 11(1):2870 - DOI
-
- Knight J, Lively MO, Johnston N et al (2005) Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 115(8):1473–1478 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources